Heterozygosity for nonsense, deletion or missense CHD7 mutations is estimated to occur in 60–80% of patients with CHARGE syndrome; these mutations are distributed throughout the coding sequence and do not appear to be correlated with specific aspects of the clinical phenotype [6], [7], [8]. This evidence concerns the gene CHD7 and CHARGE syndrome.